Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02289105 · ClinicalTrials.gov registry record · NA
Impact of Active Choice on Advance Directive Completion Rates
A NA study of Advance Directive Completion, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 1,279
- Enrollment target
- 1
- Study location
NCT02289105: Completed NA study of Advance Directive Completion, sponsored by University of Pennsylvania.
NCT02289105 is a NA study of Advance Directive Completion that has completed, run by University of Pennsylvania. The registered enrollment target is 1,279 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02289105, a NA study of Advance Directive Completion, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,279 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of this project is to assess if an active choice intervention can increase advance directive completion rates.
Primary Outcome
We will analyze the effects of the active choice intervention on rates of completion.
Conditions Studied
Interventions
- BEHAVIORAL Mandatory active choice
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,279 participants |
| Start Date | 2014-11 |
| Est. Completion | 2015-10 |
| Phase | NA |
What the finished NCT02289105 record still lists
NCT02289105 is an interventional study that assigns participants to a tested intervention. Its 1,279 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 1 condition, with Advance Directive Completion appearing as the primary indexed condition, and to 1 intervention - of which Mandatory active choice is the first listed.
NCT02289105 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02289105 about?
NCT02289105 is a clinical study titled "Impact of Active Choice on Advance Directive Completion Rates". The overall objective of this project is to assess if an active choice intervention can increase advance directive completion rates.
What is the current status of trial NCT02289105?
This trial is currently completed. It is a NA study. The enrollment target is 1,279 participants. The study started on 2014-11. Estimated completion is 2015-10.
What conditions does trial NCT02289105 study?
This clinical trial studies the following conditions: Advance Directive Completion.
What interventions are being tested in trial NCT02289105?
The interventions under investigation include: Mandatory active choice (BEHAVIORAL).
Who is sponsoring clinical trial NCT02289105?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02289105 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02289105's enrollment target sits among peer trials
1,279 78th of 2000 higher than 1,923 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- NCT06468228 · 1,280 participants · Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- NCT07207811 · 1,280 participants · Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- NCT07001800 · 1,276 participants · Phase 2
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia